In this prospective cohort study, the researchers observed an association between maternal depressive symptoms during pregnancy with slower rates of fetal growth.
The current study observed no significant differences in overall developmental outcomes or behavior in exposed versus unexposed children.
At 7 years of age, children exposed to maternal depression during pregnancy or SSRI antidepressants exhibited similar changes in white matter architecture.
Prenatal exposure to benzodiazepines and Z-hypnotics was not associated with increased risk of ADHD in exposed children.
Maternal ACEs were associated with both newborn amygdala volume and subsequent infant negative emotionality.
Neuroimaging studies indicate that exposure to antenatal depression may determine risk for later neuropsychiatric illness in the child.
When a woman comes in for a consultation regarding the use of medications during pregnancy, we spend most of our time reviewing the potential risks of exposure to medications during pregnancy. However, we must also [...]
While we have data to support the use of antidepressants, including the selective serotonin reuptake inhibitors (SSRIs) and the serotonin norepinephrine reuptake inhibitors (SNRIs), during pregnancy, most studies have focused on risk of congenital [...]
We often talk about the importance of planning for pregnancy. In these discussions, we emphasize the importance of supplementation with folic acid as a means of decreasing risk for birth defects and improving neurodevelopmental [...]
According to recent studies, the participation of fathers in childcare nearly doubled between 1965 and 2011. Despite this growing involvement of fathers in their children’s lives, pediatric visits continue to be focused on the mother-child [...]
